Search

49% of patients with symptomatic severe MR were not operated due to age, co-morbidities, or impaired LV.5 If left untreated, MR initiates a cascade of events leading to death, with 1-year mortali

ON DEMAND - TAVI SUMMIT 2025 3rd Abbott Annual Transcatheter Aortic Valve Implantation Summit SESSION 1: BEYOND THE TAVI IMPLANT: A STRATEGIC APPROACH TO LIFETIME MANAGEMENT SESSION 2: OPTIMIZING

ON DEMAND - LAAO SUMMIT 2025 14th International Left Atrial Appendage Occlusion Summit SESSION 1: PATIENT SELECTION & PRE-PROCEDURAL PLANNING SESSION 2: PROCEDURAL OPTIMIZATION & IMAGING TECHNIQUE

SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion

LEARN MORE: AMPLATZER™ TALISMAN™ PFO OCCLUDER Clinical data Diagnosis  Prevention PFO CLOSURE: BEHIND THE NUMBERS Ischemic strokes are of unknown cause5 Of patients with an isch

SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding PDA closure If PDA is left untreated, the mortality rate is 20% by age 20 years,

Tendyne™ TMVR improves your patients’ function and quality of life, with clinically significant improvement in a 6-minute walk test2 and Kansas City Cardiomyopathy Questionnaire (KCCQ) scores.1 The

PATIENTS WHO BENEFIT MR IS THE MOST COMMON VALVULAR HEART DISEASE AND IS SIGNIFICANTLY UNDERTREATED3 More patients are suffering from MR than any other valve disease, and only a small percentage

LEARN MORE: AMPLATZER™ DUCT OCCLUDERS   AMPLATZER™ PICCOLO™ OCCLUDER WATCH ON-DEMAND:​ PDA Symposium 2024 If PDA is left untreated, the mortality rate is 20% by age 20 years,

AF AND STROKE ARE OFTEN CONNECTED MORE SEVERE LEARN MORE: PATIENTS WHO BENEFIT Clinical Data